Ownership of Niox Group PLC is distributed among institutional asset managers and strategic corporate stakeholders, with prominent entities such as Harwood Capital Management and AstraZeneca PLC holding significant equity blocks. Additional institutional investors, including specialized smaller companies investment trusts and mutual funds, hold the remaining public shares traded on the London Stock Exchange's AIM market.